Study cohorts
Study cohorts are key to our research aimed at investigating the mechanisms that lead to type 1 diabetes (T1D) and to discover novel biomarkers capable of predicting disease development and to follow auto-immune progression during disease course and regression following immune intervention.

Two study cohorts are currently running; the ImMaDiab cohort, which explores the natural history of the autoimmune T-cell responses and of beta-cell decline short after T1D onset; and the TRAKR cohort, which explores the natural history of autoimmune progression in at-risk children born from T1D parents.